These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23222171)

  • 21. The evaluation of citizen participation in policymaking: Insights from Portugal.
    Falanga R; Ferrão J
    Eval Program Plann; 2021 Feb; 84():101895. PubMed ID: 33285398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citizen participation and discontent in three Southern European health systems.
    Serapioni M; Matos AR
    Soc Sci Med; 2014 Dec; 123():226-33. PubMed ID: 24947551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.
    Nelson KC; Andow DA; Banker MJ
    J Law Med Ethics; 2009; 37(4):732-48. PubMed ID: 20122113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avoiding empty rhetoric: engaging publics in debates about nanotechnologies.
    Kyle R; Dodds S
    Sci Eng Ethics; 2009 Mar; 15(1):81-96. PubMed ID: 18825510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Art for public engagement on emerging and controversial technologies: A literature review.
    Fraaije A; van der Meij MG; Kupper F; Broerse JEW
    Public Underst Sci; 2022 Aug; 31(6):694-710. PubMed ID: 35570661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Science, ethics, and the "problems" of governing nanotechnologies.
    Hogle LF
    J Law Med Ethics; 2009; 37(4):749-58. PubMed ID: 20122114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Too small for concern? Public health and nanotechnology.
    Bowman DM; Fitzharris M
    Aust N Z J Public Health; 2007 Aug; 31(4):382-4. PubMed ID: 17725022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reflecting on public engagement and science policy.
    Jones RA
    Public Underst Sci; 2014 Jan; 23(1):27-31. PubMed ID: 24434708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crowdsourcing conservation: The role of citizen science in securing a future for seagrass.
    Jones BL; Unsworth RKF; McKenzie LJ; Yoshida RL; Cullen-Unsworth LC
    Mar Pollut Bull; 2018 Sep; 134():210-215. PubMed ID: 29137812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citizen science as seen by scientists: Methodological, epistemological and ethical dimensions.
    Riesch H; Potter C
    Public Underst Sci; 2014 Jan; 23(1):107-20. PubMed ID: 23982281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Including citizens in institutional reviews: expectations and experiences from the Dutch Healthcare Inspectorate.
    Adams SA; van de Bovenkamp H; Robben P
    Health Expect; 2015 Oct; 18(5):1463-73. PubMed ID: 24112128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citizen Science for public health.
    Den Broeder L; Devilee J; Van Oers H; Schuit AJ; Wagemakers A
    Health Promot Int; 2018 Jun; 33(3):505-514. PubMed ID: 28011657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research on Citizen Participation in Government Ecological Environment Governance Based on the Research Perspective of "Dual Carbon Target".
    Chen S; Liu N
    J Environ Public Health; 2022; 2022():5062620. PubMed ID: 35769833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsibility, rationality, and acceptance: How future users of autonomous driving are constructed in stakeholders' sociotechnical imaginaries.
    Graf A; Sonnberger M
    Public Underst Sci; 2020 Jan; 29(1):61-75. PubMed ID: 31709906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redesigning the architecture of policy-making: Engaging with Māori on nanotechnology in New Zealand.
    Munshi D; Kurian PA; Morrison T; Morrison SL
    Public Underst Sci; 2016 Apr; 25(3):287-302. PubMed ID: 25193966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foresight Study on the Risk Governance of New Technologies: The Case of Nanotechnology.
    Read SA; Kass GS; Sutcliffe HR; Hankin SM
    Risk Anal; 2016 May; 36(5):1006-24. PubMed ID: 26332140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards a more effective and efficient governance and regulation of nanomaterials.
    Teunenbroek TV; Baker J; Dijkzeul A
    Part Fibre Toxicol; 2017 Dec; 14(1):54. PubMed ID: 29258600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory approaches to worker protection in nanotechnology industry in the USA and European union.
    Murashov V; Schulte P; Geraci C; Howard J
    Ind Health; 2011; 49(3):280-96. PubMed ID: 21372443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Openness in participation, assessment, and policy making upon issues of environment and environmental health: a review of literature and recent project results.
    Pohjola MV; Tuomisto JT
    Environ Health; 2011 Jun; 10():58. PubMed ID: 21679456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What does the history of technology regulation teach us about nano oversight?
    Marchant GE; Sylvester DJ; Abbott KW
    J Law Med Ethics; 2009; 37(4):724-31. PubMed ID: 20122112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.